Form 4: Modine Manufacturing VP Exercises Options, Sells Shares Under Pre-Arranged Plan
Insider Trading Report
Modine Manufacturing's VP and CHRO, Brian Jon Agen, executed a pre-arranged trading plan, exercising stock options and selling an equivalent number of common shares on July 29, 2025.
Summary
- Brian Jon Agen, VP, CHRO of Modine Manufacturing Co. (MOD), completed a series of stock option exercises and subsequent share sales on July 29, 2025.
- The transactions were executed under a Rule 10b5-1 trading plan established on December 18, 2024, marking the completion of activity under that plan.
- Agen exercised options to acquire a total of 47,939 shares of common stock at exercise prices ranging from $6.62 to $17.90 per share.
- Concurrently, Agen sold a total of 47,939 shares of common stock at weighted average prices ranging from $110.3301 to $112.49 per share.
- Following these transactions, Agen's direct beneficial ownership of Modine common stock is 90,015 shares, which includes 1,474 units held in his 401(k) Retirement Plan account.
Sentiment
Score: 7
Explanation: The sentiment is positive for the insider as they realized significant gains from exercising options and selling shares. For the company, it is neutral as it is a routine compensation event under a pre-arranged plan, indicating no immediate negative signals about the company's prospects.
Positives
- The transactions demonstrate a significant profit for the insider, as shares acquired at low option exercise prices were sold at substantially higher market prices.
- The execution of transactions under a Rule 10b5-1 plan indicates pre-planned, non-discretionary trading, which can mitigate concerns about opportunistic insider trading.
Negatives
- The sale of 47,939 shares by a key executive could be perceived as a reduction in direct stake, although it is part of a pre-arranged compensation realization.
Future Outlook
NA
Industry Context
This filing details an individual executive's compensation-related stock transactions and does not provide broader insights into industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: The sale of shares by a key executive could be viewed as a slight reduction in insider alignment, but the pre-arranged nature via a 10b5-1 plan mitigates concerns about opportunistic selling. The transactions are a routine part of executive compensation realization.
Key Dates
| Date | Description |
|---|---|
| 10/02/2021 | First installment vesting date for an employee stock option. |
| 06/04/2022 | First installment vesting date for an employee stock option. |
| 10/02/2022 | Second installment vesting date for an employee stock option. |
| 06/06/2023 | First 33% vesting date for an employee stock option. |
| 06/04/2023 | Second installment vesting date for an employee stock option. |
| 10/02/2023 | Third installment vesting date for an employee stock option. |
| 12/18/2024 | Date Brian Jon Agen entered into the Rule 10b5-1 trading plan. |
| 06/06/2024 | Second 33% vesting date for an employee stock option. |
| 06/04/2024 | Third installment vesting date for an employee stock option. |
| 10/02/2024 | Fourth installment vesting date for an employee stock option. |
| 07/29/2025 | Date of stock option exercises and common stock sales. |
| 06/04/2025 | Fourth installment vesting date for an employee stock option. |
| 06/06/2025 | Remaining 34% vesting date for an employee stock option. |
| 05/29/2029 | Expiration date for an employee stock option. |
| 10/02/2030 | Expiration date for an employee stock option. |
| 06/04/2031 | Expiration date for an employee stock option. |
| 06/06/2032 | Expiration date for an employee stock option. |
Recommendation
holdThe filing is a routine Form 4 detailing an executive's exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. While the executive realized significant gains, this is a standard compensation event and does not provide new fundamental information about the company's operational performance or future prospects that would warrant a change in investment recommendation. The stock's performance should be evaluated based on broader financial results and market conditions, not solely on this insider transaction.
Keywords
Modine Manufacturing, MOD, SEC Form 4, Insider Trading, Stock Options, Rule 10b5-1 Plan, Executive Compensation, Brian Jon Agen, Share Sale, Option Exercise
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.